NASDAQ · MRVI
Maravai LifeSciences Holdings, Inc.
$8.46-$0.04 (-0.47%)
Maravai LifeSciences Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.19% below the high.
Loading market information…
NYSE · AMN · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
AMN Healthcare Services, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AMN Healthcare Services, Inc.’s forward annual dividend is $1.20 per share, paid quarterly. The forward yield is 2.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
AMN Healthcare Services, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.23. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow AMN Healthcare Services, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 8, 2025 | $0.45+136.84% vs estimate | $689.53M+2.9% vs estimate |
|---|
| Q4 2024 | Feb 20, 2025 | $0.75+44.23% vs estimate | $734.71M+5.81% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | $0.61+5.17% vs estimate | $687.51M+2.93% vs estimate |
|---|
THE ANALYST VIEW
17 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 4 contributors · Median target $38.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$8.46-$0.04 (-0.47%)
Maravai LifeSciences Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.19% below the high.
$7.51-$0.30 (-3.84%)
Butterfly Network, Inc.’s quoted price sits in the upper half of its reported 52-week range, 26.44% below the high.
$17.39+$1.33 (+8.28%)
Replimune Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.19% below the high.
$12.19-$0.09 (-0.73%)
COMPASS Pathways plc’s quoted price sits in the upper half of its reported 52-week range, 23.19% below the high.
$210.10-$2.53 (-1.19%)
Nutex Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
$33.80+$0.07 (+0.21%)
HealthStream, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
$12.74-$0.58 (-4.35%)
Ginkgo Bioworks Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 30.08% below the high.
$6.67+$0.04 (+0.6%)
Myriad Genetics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.41% below the high.
